TAYTON-MARTIN HELEN KATRINA

Insider CIK 1661780 · TRIL Director · ADAP Chief Operating Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
ADAP Adaptimmune Therapeutics P	A Award deriv	2024-01-15	2024-01-17	565,416	—	$0	565,416	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2024-01-15	2024-01-17	2,544,432	—	$0	2,544,432	SEC↗
ADAP] Adaptimmune Therapeutics P	A Award deriv	2023-01-17	2023-01-17	197,064	—	$0	197,064	SEC↗
ADAP] Adaptimmune Therapeutics P	A Award deriv	2023-01-17	2023-01-17	314,256	—	$0	314,256	SEC↗
ADAP] Adaptimmune Therapeutics P	A Award deriv	2023-01-17	2023-01-17	1,407,072	—	$0	1,407,072	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2022-01-12	2022-01-13	314,256	—	$0	314,256	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2022-01-12	2022-01-13	1,407,072	—	$0	1,407,072	SEC↗
TRIL Trillium Therapeutics Inc.	D To issuer deriv	2021-11-17	2021-11-19	498,294	—	$0	0	SEC↗
TRIL Trillium Therapeutics Inc.	D To issuer deriv	2021-11-17	2021-11-19	40,000	—	$0	0	SEC↗
ADAP Adaptimmune Therapeutics P	M Exercise	2021-03-03	2021-03-03	1,785,000	$0.16	$285.6K	1,800,000	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2021-01-11	2021-01-11	242,712	—	$0	242,712	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2021-01-11	2021-01-11	1,086,816	—	$0	1,086,816	SEC↗
ADAP Adaptimmune Therapeutics P	S Sale	2020-08-03	2020-08-04	200,000	$8.74	$1.75M	0	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2020-01-16	2020-01-17	1,257,744	—	$0	1,257,744	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2020-01-16	2020-01-17	280,896	—	$0	280,896	SEC↗
ADAP Adaptimmune Therapeutics P	S Sale	2020-01-13	2020-01-15	50,000	$5.00	$250.0K	0	SEC↗
ADAP Adaptimmune Therapeutics P	S Sale	2020-01-13	2020-01-15	50,000	$4.00	$200.0K	0	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2019-01-04	2019-01-08	1,006,224	—	$0	1,006,224	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2019-01-04	2019-01-08	224,724	—	$0	224,724	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2018-01-12	2018-01-17	153,648	—	$0	153,648	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2018-01-12	2018-01-17	687,984	—	$0	687,984	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2017-01-13	2017-01-18	2,072,976	—	$0	2,072,976	SEC↗
ADAP Adaptimmune Therapeutics P	A Award deriv	2016-01-18	2016-01-20	939,948	—	$0	939,948	SEC↗